These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28405629)

  • 1. Human Norovirus Evolution in a Chronically Infected Host.
    Doerflinger SY; Weichert S; Koromyslova A; Chan M; Schwerk C; Adam R; Jennewein S; Hansman GS; Schroten H
    mSphere; 2017; 2(2):. PubMed ID: 28405629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of GII.4 norovirus persistence in human populations.
    Lindesmith LC; Donaldson EF; Lobue AD; Cannon JL; Zheng DP; Vinje J; Baric RS
    PLoS Med; 2008 Feb; 5(2):e31. PubMed ID: 18271619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human noroviruses' fondness for histo-blood group antigens.
    Singh BK; Leuthold MM; Hansman GS
    J Virol; 2015 Feb; 89(4):2024-40. PubMed ID: 25428879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Norovirus Neutralized by a Monoclonal Antibody Targeting the Histo-Blood Group Antigen Pocket.
    Koromyslova AD; Morozov VA; Hefele L; Hansman GS
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Within-host evolution results in antigenically distinct GII.4 noroviruses.
    Debbink K; Lindesmith LC; Ferris MT; Swanstrom J; Beltramello M; Corti D; Lanzavecchia A; Baric RS
    J Virol; 2014 Jul; 88(13):7244-55. PubMed ID: 24648459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human norovirus inhibition by a human milk oligosaccharide.
    Koromyslova A; Tripathi S; Morozov V; Schroten H; Hansman GS
    Virology; 2017 Aug; 508():81-89. PubMed ID: 28505592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Basis for Human Norovirus Capsid Binding to Bile Acids.
    Kilic T; Koromyslova A; Hansman GS
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30355683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Norovirus Interactions with Histo-Blood Group Antigens and Human Milk Oligosaccharides.
    Schroten H; Hanisch FG; Hansman GS
    J Virol; 2016 Jul; 90(13):5855-5859. PubMed ID: 27122582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural analysis of determinants of histo-blood group antigen binding specificity in genogroup I noroviruses.
    Shanker S; Czako R; Sankaran B; Atmar RL; Estes MK; Prasad BV
    J Virol; 2014 Jun; 88(11):6168-80. PubMed ID: 24648450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pandemic GII.4 Sydney and Epidemic GII.17 Kawasaki308 Noroviruses Display Distinct Specificities for Histo-Blood Group Antigens Leading to Different Transmission Vector Dynamics in Pacific Oysters.
    Morozov V; Hanisch FG; Wegner KM; Schroten H
    Front Microbiol; 2018; 9():2826. PubMed ID: 30542329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conservation of carbohydrate binding interfaces: evidence of human HBGA selection in norovirus evolution.
    Tan M; Xia M; Chen Y; Bu W; Hegde RS; Meller J; Li X; Jiang X
    PLoS One; 2009; 4(4):e5058. PubMed ID: 19337380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population Genomics of GII.4 Noroviruses Reveal Complex Diversification and New Antigenic Sites Involved in the Emergence of Pandemic Strains.
    Tohma K; Lepore CJ; Gao Y; Ford-Siltz LA; Parra GI
    mBio; 2019 Sep; 10(5):. PubMed ID: 31551337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-Host Evolution of Norovirus GII.4 in a Chronic Infected Patient With Hematopoietic Stem Cell Transplantation.
    Yu JM; Liang ZY; Guo K; Sun XM; Zhang Q; Dong YJ; Duan ZJ
    Front Microbiol; 2020; 11():375. PubMed ID: 32210947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct Blockade of the Norovirus Histo-Blood Group Antigen Binding Pocket by Nanobodies.
    Kher G; Sabin C; Lun JH; Devant JM; Ruoff K; Koromyslova AD; von Itzstein M; Pancera M; Hansman GS
    J Virol; 2023 Apr; 97(4):e0183322. PubMed ID: 36971561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric VLPs with GII.3 P2 domain in a backbone of GII.4 VP1 confers novel HBGA binding ability.
    Huo Y; Wang W; Ling T; Wan X; Ding L; Shen S; Huo J; Zhang S; Wang M; Wang Y; Liu Y
    Virus Res; 2016 Sep; 224():1-5. PubMed ID: 27521750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Noroviruses--tactic of spread].
    Gospodarek E; Zalas-Wiecek P
    Przegl Epidemiol; 2009; 63(1):5-9. PubMed ID: 19522218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a Novel Conformational GII.4 Norovirus Epitope: Implications for Norovirus-Host Interactions.
    Carmona-Vicente N; Vila-Vicent S; Allen D; Gozalbo-Rovira R; Iturriza-Gómara M; Buesa J; Rodríguez-Díaz J
    J Virol; 2016 Sep; 90(17):7703-14. PubMed ID: 27307569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norovirus GII.4 and GII.7 capsid sequences undergo positive selection in chronically infected patients.
    Hoffmann D; Hutzenthaler M; Seebach J; Panning M; Umgelter A; Menzel H; Protzer U; Metzler D
    Infect Genet Evol; 2012 Mar; 12(2):461-6. PubMed ID: 22310302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural analysis of a rabbit hemorrhagic disease virus binding to histo-blood group antigens.
    Leuthold MM; Dalton KP; Hansman GS
    J Virol; 2015 Feb; 89(4):2378-87. PubMed ID: 25505081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phylogenetic Analyses Suggest that Factors Other Than the Capsid Protein Play a Role in the Epidemic Potential of GII.2 Norovirus.
    Tohma K; Lepore CJ; Ford-Siltz LA; Parra GI
    mSphere; 2017; 2(3):. PubMed ID: 28529975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.